Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (FY)Nov 30, 2025 | (Q4)Nov 30, 2025 | (Q3)Aug 31, 2025 | (Q2)May 31, 2025 | (Q1)Feb 28, 2025 | (FY)Nov 30, 2024 | (Q4)Nov 30, 2024 | (Q3)Aug 31, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 151.54%62.1K | 685.12%67.07K | -112.67%-12.77K | 212.90%31.07K | 87.24%-23.27K | 68.73%-120.5K | 89.75%-11.46K | 162.61%100.77K | 13.41%-27.52K | -125.76%-182.29K |
| Net income from continuing operations | 24.11%-275.07K | -3.36%-238.08K | -220.89%-33.7K | 82.24%-11.5K | 108.61%8.21K | 9.33%-362.48K | -18.37%-230.34K | 161.47%27.87K | 22.19%-64.75K | 28.17%-95.27K |
| Operating gains losses | ---67.55K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 2.53%257.79K | 0.82%64.07K | -0.53%62.94K | 2.75%64.75K | 7.22%66.03K | 135.12%251.42K | -18.69%63.55K | 119.86%63.27K | --63.02K | --61.58K |
| Asset impairment expenditure | -76.45%20.96K | -82.58%15.51K | ---62 | ---- | ---- | --89K | --89K | --0 | ---- | ---- |
| Remuneration paid in stock | -30.01%20.32K | -83.55%1.5K | -83.00%1.51K | 10.29%12.19K | --5.12K | -92.86%29.03K | --9.09K | -97.81%8.89K | --11.05K | --0 |
| Other non cashItems | -38.67%24.84K | -9.33%6.42K | 15.57%10.47K | -66.17%3.99K | -68.43%3.97K | 90.41%40.51K | -44.58%7.08K | --9.06K | --11.8K | --12.58K |
| Change In working capital | 148.11%80.82K | 468.53%285.22K | -548.56%-53.93K | 9.78%-43.88K | 33.87%-106.59K | -3,747.54%-167.97K | 716,571.43%50.17K | 92.02%-8.32K | -194.53%-48.64K | -381.01%-161.18K |
| -Change in receivables | -904.25%-90.63K | -62.81%38.49K | 27.21%-35.41K | -140.08%-21.29K | -108.55%-72.42K | 105.64%11.27K | 375.89%103.51K | 69.96%-48.65K | -340.62%-8.87K | -806.47%-34.73K |
| -Change in inventory | 181.46%107.54K | 248.54%91.62K | 175.67%47.5K | 72.29%-17.61K | 41.86%-13.97K | ---132.02K | ---61.69K | --17.23K | ---63.54K | ---24.02K |
| -Change in prepaid assets | -150.57%-1.86K | 3,883.23%6.09K | 632.98%6.22K | 1,994.42%31.17K | -3,130.48%-45.34K | 176.98%3.67K | -100.90%-161 | 107.24%849 | 114.90%1.49K | 251.42%1.5K |
| -Change in payables and accrued expense | 229.22%65.76K | 1,652.43%149.01K | -424.59%-72.23K | -262.20%-36.15K | 124.18%25.13K | -124.35%-50.89K | -56.60%8.5K | -67.97%22.25K | -61.41%22.28K | -267.16%-103.93K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 151.54%62.1K | 685.12%67.07K | -112.67%-12.77K | 212.90%31.07K | 87.24%-23.27K | 68.73%-120.5K | 89.75%-11.46K | 162.61%100.77K | 13.41%-27.52K | -125.76%-182.29K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 98.78%-11.56K | 0 | 0 | -341,481.82%-75.1K | -431.60%-24.02K | ||
| Net PPE purchase and sale | --0 | --0 | --0 | ---- | ---- | -647.18%-11.56K | --0 | --0 | -52,654.55%-11.56K | --0 |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --17.23K | ---63.54K | ---24.02K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | ---- | ---- | 98.78%-11.56K | --0 | --0 | -341,481.82%-75.1K | -431.60%-24.02K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 46.20%-90.2K | -155.46%-6.95K | 91.51%-6.73K | 87.89%-12.07K | -5,399.23%-64.45K | -109.51%-167.65K | 622.35%12.53K | -105.23%-79.29K | -156.96%-99.71K | -101.55%-1.17K |
| Net issuance payments of debt | 41.99%-178.53K | --0 | --0 | --0 | ---178.53K | ---307.73K | -183.71%-102.56K | 84.72%-34.08K | -783.12%-171.1K | --0 |
| Net common stock issuance | --0 | ---- | ---- | ---- | ---- | -94.27%114.52K | --114.52K | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | --0 | --0 | --0 | ---- | ---- | --25K | --0 | --0 | ---- | ---- |
| Net other financing activities | 15,505.30%88.33K | ---6.95K | ---6.73K | -126.02%-12.07K | 9,833.36%114.08K | 100.24%566 | ---- | ---- | --46.38K | ---1.17K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 46.20%-90.2K | -155.46%-6.95K | 91.51%-6.73K | 87.89%-12.07K | -5,399.23%-64.45K | -109.51%-167.65K | 622.35%12.53K | -105.23%-79.29K | -156.96%-99.71K | -101.55%-1.17K |
| Net cash flow | ||||||||||
| Beginning cash position | -69.05%129.54K | -70.01%34.56K | -45.57%53.63K | -78.18%51.3K | -69.05%129.54K | 4,900.29%418.52K | -79.97%115.23K | -35.90%98.53K | 2,157.99%235.08K | 4,900.29%418.52K |
| Current changes in cash | 90.62%-28.1K | 5,550.38%60.12K | -190.78%-19.5K | 113.69%19K | 52.19%-87.72K | -169.68%-299.71K | 100.83%1.06K | -94.81%21.48K | -196.86%-138.79K | -9,088.93%-183.46K |
| Effect of exchange rate changes | -93.22%728 | -43.47%7.49K | 109.10%435 | -844.71%-16.67K | 49,768.42%9.48K | 153.70%10.73K | 147.82%13.25K | -161.83%-4.78K | --2.24K | --19 |
| End cash Position | -21.13%102.17K | -21.13%102.17K | -70.01%34.56K | -45.57%53.63K | -78.18%51.3K | -69.05%129.54K | -69.05%129.54K | -79.97%115.23K | -35.90%98.53K | 2,157.99%235.08K |
| Free cash from | 147.03%62.1K | 685.12%67.07K | -112.67%-12.77K | 179.50%31.07K | 87.24%-23.27K | 66.18%-132.06K | 89.75%-11.46K | 160.67%100.77K | -22.97%-39.08K | -125.76%-182.29K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.